Senar Brings Early breast Cancer Detection to Rural Women

brasilia (2025/10/28 22:59:51) – The National Rural Learning Service (Senar) will launch a pilot project in November, bringing an innovative blood test for breast cancer screening to women in rural areas of São Paulo and Ceará.

The action is integrated into the “Semear é Cuidar” program in São Paulo and “Saúde da Mulher Rural” in quixadá (CE). These initiatives, respectively, focus on complete care and women’s rural health. senar aims to improve access to early detection, which is crucial for successful treatment.

the blood test, developed by the Brazilian company OncoPain, detects circulating tumor cells, offering a non-invasive alternative to traditional mammography. This is particularly important for women in remote areas who may face logistical challenges accessing traditional screening methods.The test analyzes a small blood sample for the presence of these cells, perhaps indicating the presence of breast cancer even before symptoms appear.

During the pilot phase, approximately 500 women will be screened. Senar will provide training to health agents who will administer the tests and collect samples. Samples will then be sent to OncoPain’s laboratory for analysis. Results will be communicated to participants by healthcare professionals, who will guide them through any necessary follow-up care.

“This partnership with OncoPain represents a notable step forward in our commitment to the health and well-being of rural communities,” states a senar representative. “We believe this innovative screening method will empower women to take control of their health and improve their chances of early detection and successful treatment.”

Key Takeaways

• Senar is piloting a new blood test for breast cancer screening in rural São Paulo and Ceará.
• The test, developed by OncoPain, detects circulating tumor cells.
• Approximately 500 women will participate in the initial pilot program.
• The initiative aims to improve access to early detection for women in remote areas.
• Results will be communicated by healthcare professionals, ensuring appropriate follow-up care.

FAQ

What is the benefit of a blood test over a mammogram?

The blood test offers a non-invasive alternative, which is particularly beneficial for women in rural areas with limited access to mammography facilities. It can also detect cancer cells earlier, potentially before symptoms develop.

How accurate is the blood test?

The blood test is a screening tool,and its accuracy is continually being evaluated. positive results will always require confirmation with further diagnostic testing, such as a mammogram or biopsy.

Who is eligible to participate in the pilot program?

Women residing in participating rural communities in São Paulo and Ceará will be eligible. Specific eligibility criteria will be resolute by Senar and communicated through local health agents.

what happens after the blood test?

Participants will receive their results from a healthcare professional. If the test indicates a potential concern, further diagnostic testing will be recommended.